Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage

Objectives: This study was conducted to examine a complex effect of ciprofibrate therapy in patients with atherogenic lipoprotein phenotype. Methods: Effects of ciprofibrate were studied on HDL subpopulations, HDL ability to esterify cholesterol (FERHDL), susceptibility of LDL to oxidation as well as on in vivo oxidative DNA damage in peripheral lymphocytes… CONTINUE READING